Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
4.920
+0.320 (6.96%)
Nov 19, 2025, 3:18 PM EST - Market open
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $19.4 million as of November 19, 2025. Its market cap has decreased by -16.69% in one year.
Market Cap
19.40M
Enterprise Value
-6.17M
1-Year Change
-16.69%
Ranking
Category
Stock Price
$4.92
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $19.40M, a decrease of -96.04%. That is a compound annual growth rate of -46.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 18.14M | -20.03% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |